Ajmaline
From Self-sufficiency
| File:Ajmaline.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
(17R,21β)-ajmalan- 17,21-diol OR (1R,9R,10S,13R,14R,16S,18S)- 13-ethyl- 8-methyl- 8,15-diazahexacyclo [14.2.1.01,9.02,7.010,15.012,17] nonadeca- 2(7),3,5-triene- 14,18-diol | |
| Identifiers | |
| CAS Number | 4360-12-7 |
| ATC code | C01BA05 (WHO) |
| PubChem | CID 20367 |
| DrugBank | DB01426 |
| ChemSpider | 10469368 |
| Chemical data | |
| Formula | C20H26N2O2 |
| Molar mass | 326.433 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Ajmaline is a class Ia antiarrhythmic agent. It is often used to bring out typical findings of ST elevations in patients suspected of having Brugada syndrome.
The compound was first isolated by Salimuzzaman Siddiqui in 1931 [1] from the roots of Rauwolfia serpentina. He named it ajmaline, after Hakim Ajmal Khan, one of the most illustrious practitioners of Unani medicine in South Asia.[2]
See also
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
- ↑ Siddiqui, S.; Siddiqui, R. H. (1931). J. Indian Chem. Soc. 8: 667–80.
- ↑ Ahmed Nasim Sandilvi (2003), Salimuzzaman Siddiqui: pioneer of scientific research in Pakistan. Daily Dawn. 12 April 2003. Retrieved on 19 July 2007.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Antiarrhythmic agents
- Alkaloids
- Alcohols
- Sodium channel blockers
- Cardiovascular system drug stubs
